Référentiel des médicaments
Rozanolixizumab
Rozanolixizumab is a medicine in the class miscellaneous. It is used for myasthenia gravis.
- Classe médicamenteuse: Miscellaneous
- Indications: myasthenia gravis
Dernière mise à jour Sources: US FDA label
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
L'essentiel
- Classe médicamenteuse
- Miscellaneous
- Code ATC
- L04AL02
- Formes courantes
- injection
- Dosages courants
- 140 mg/ml
- Interactions connues
- 26 (Majeure: 1 · Modérée: 25)
- Noms commerciaux
- 2
- Pays et marchés
- 2
Indications
Mécanisme d'action
Humanized IgG4 monoclonal antibody that binds the neonatal Fc receptor (FcRn), reducing circulating IgG.
Posologie adulte habituelle (résumé de la notice)
Generalized myasthenia gravis, body weight less than 50 kg: 420 mg (3 mL), subcutaneous infusion, once weekly for 6 weeks
Grossesse et allaitement
- Grossesse
- Unknown Limited human data. US label: in monkeys it caused embryo death, low offspring weight and weak immune function at 10 to 30 times the human dose without maternal toxicity; the EU label reads the same studies as low IgG only. It lowers IgG passed to the baby; weigh live vaccines for the infant.
- Allaitement
- Unknown No human milk data; IgG passes into milk. US label: weigh benefits. EU label: a risk cannot be excluded in the first days after birth; afterwards consider use only if the benefit outweighs the risk. No LactMed record. A large antibody, so infant absorption is likely low.
Effets indésirables signalés
- Headache
- Infections
- Diarrhea
- Pyrexia
- Hypersensitivity reactions
- Nausea
Précautions particulières
- Infections: may increase infection risk; delay in active infection, monitor, and consider withholding for serious infection.
- Live or live-attenuated vaccines are not recommended during treatment because of reduced IgG.
- Aseptic meningitis: serious cases reported; start diagnostic workup and treatment if symptoms develop.
Informez votre pharmacien ou votre médecin en cas de grossesse ou d'allaitement, de maladie rénale ou hépatique, d'allergies, ainsi que de tout autre médicament ou complément que vous prenez.
Principales interactions (26)
- Rozanolixizumab + Upadacitinib Major
- Abatacept + Rozanolixizumab Moderate
- Adalimumab + Rozanolixizumab Moderate
- Ado-trastuzumab + Rozanolixizumab Moderate
- Basiliximab + Rozanolixizumab Moderate
- Bevacizumab + Rozanolixizumab Moderate
- Denosumab + Rozanolixizumab Moderate
- Etanercept + Rozanolixizumab Moderate
- Galcanezumab + Rozanolixizumab Moderate
- Golimumab + Rozanolixizumab Moderate
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour ouvrir la monographie complète de Rozanolixizumab : posologie, grossesse et allaitement, effets indésirables, mises en garde et toutes les interactions.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- How to give it
- Pharmacokinetics
- Patient counselling points
- IV preparation and dilution
Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.
Autres médicaments de cette classe
Questions fréquentes
What is Rozanolixizumab used for?
Rozanolixizumab is a medicine in the class miscellaneous. It is used for Myasthenia gravis.
What side effects have been reported with Rozanolixizumab?
Headache, Infections, Diarrhea, Pyrexia, Hypersensitivity reactions, Nausea.
Can Rozanolixizumab be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Limited human data. US label: in monkeys it caused embryo death, low offspring weight and weak immune function at 10 to 30 times the human dose without maternal toxicity; the EU label reads the same studies as low IgG only. It lowers IgG passed to the baby; weigh live vaccines for the infant. Breastfeeding: Unknown. No human milk data; IgG passes into milk. US label: weigh benefits. EU label: a risk cannot be excluded in the first days after birth; afterwards consider use only if the benefit outweighs the risk. No LactMed record. A large antibody, so infant absorption is likely low.
What does Rozanolixizumab interact with?
MediHelp lists 26 known interactions for Rozanolixizumab. Major: 1 · Moderate: 25. The most serious include Upadacitinib, Abatacept, Adalimumab.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.